Viewing Study NCT06984094

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-02-08 @ 11:26 AM
Study NCT ID: NCT06984094
Status: RECRUITING
Last Update Posted: 2025-08-08
First Post: 2025-05-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
Sponsor: Clover Biopharmaceuticals AUS Pty
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Respiratory Syncytial Virus Vaccination View
None Human Metapneumovirus Vaccination View
None Parainfluenza Vaccination View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Respiratory Syncytial Virus vaccination View
None Human Matapneumovirus vaccination View
None Parainfluenza vaccination View
None healthy volunteers View